Abstract
Itch is the most common clinical problem seen in dogs with skin diseases. Although an etiological classification of canine pruritus does not yet exist, most causes would likely fall into the IFSI class I (dermatological) itch. One of the most common causes of canine itch is that associated with atopic dermatitis, and there is randomized controlled trial grade evidence of the efficacy of several antipruritic interventions. At this time, the mainstay of treatment of canine atopic itch relies principally on the use of topical and/or oral glucocorticoids and oral cyclosporine. Type 1 receptor antihistamines are notorious in their inconsistency in reducing pruritus in atopic dogs. A new Janus kinase (JAK)-1 inhibitor has recently been approved for treatment of allergic itch in dogs, and its onset of efficacy is remarkably fast. Modeling itch in dogs can be achieved by allergen sensitization (fleas, house dust mites), and challenges that elicit pruritic manifestation can be used for mechanistic studies as well as for testing of novel anti-itch modalities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Atopic dermatitis
- JAK:
-
Janus kinase
- NFAT:
-
Nuclear factor of activated T cells
- NT:
-
Not tested
- PAR:
-
Proteinase-activated receptor
- RCT:
-
Randomized controlled trial
- VAS:
-
Visual analog scale
References
Akiyama T, Carstens E (2013) Neural processing of itch. Neuroscience 250:697–714
Archer TM, Fellman CL, Stokes JV, Pinchuk LM, Lunsford KV, Pruett SB, Langston VC, Mackin AJ (2011) Pharmacodynamic monitoring of canine T-cell cytokine responses to oral cyclosporine. J Vet Intern Med 25:1391–1397
Baumer W, Kietzmann M (2007) Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes. Vet Dermatol 18:107–114
Baumer W, Stahl J, Sander K, Petersen LJ, Paps J, Stark H, Kietzmann M, Olivry T (2011) Lack of preventing effect of systemically and topically administered histamine H(1) or H(4) receptor antagonists in a dog model of acute atopic dermatitis. Exp Dermatol 20:577–581
Bonneau S, Skowronski V, Sanquer A, Maynard L, Eun HM (2009) Therapeutic efficacy of topical hydrocortisone aceponate in experimental flea-allergy dermatitis in dogs. Aust Vet J 87:287–291
Carr MN, Torres SM, Koch SN, Reiter LV (2009) Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs. Vet Dermatol 20:105–110
Cosgrove SB, Wren JA, Cleaver DM, Martin DD, Walsh KF, Harfst JA, Follis SL, King VL, Boucher JF, Stegemann MR (2013) Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol 24:479–e114
DeBoer DJ, Schafer JH, Salsbury CS, Blum JR, Beale KM, Vitale CB, Muse R, Moriello KA, Garfield RA, Keefe TJ, McArthur TR (2002) Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus. Am J Vet Res 63:408–413
Dell DL, Griffin CE, Thompson LA, Griffies JD (2012) Owner assessment of therapeutic interventions for canine atopic dermatitis: a long-term retrospective analysis. Vet Dermatol 23:228–e47
Dip R, Carmichael J, Letellier I, Strehlau G, Roberts E, Bensignor E, Rosenkrantz W (2013) Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis. BMC Vet Res 9:173
Eichenseer M, Johansen C, Mueller RS (2013) Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial. Vet Rec 173:423–427
Fleck T, Humphrey W, Coscarelli E, Galvan B, Aleo M, Gonzales A, Shelly J, Mahabir S, McCall RB (2012) Comparison of the janus kinase (JAK) inhibitor, oclacitinib, and prednisolone in canine models of pruritus. Vet Dermatol 23 (Suppl. 1):38 (abstract)
Fric J, Zelante T, Wong AY, Mertes A, Yu HB, Ricciardi-Castagnoli P (2012) NFAT control of innate immunity. Blood 120:1380–1389
Gonzales AJ, Bowman J, Fici G, Zhang M, Mann DW (2013a) Oclacitinib (Apoquel"; Zoetis) is a novel Janus kinase inhibitor that has activity against canine pro-allergic and pro- inflammatory cytokines. Vet Dermatol 24:384 (abstract)
Gonzales AJ, Humphrey WR, Messamore JE, Fleck TJ, Fici GJ, Shelly JA, Teel JF, Bammert GF, Dunham SA, Fuller TE, McCall RB (2013b) Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 24:48–53.e11-2
Hendricks A, Elson-Riggins JG, Riddle AL, House AK, Varjonen K, Bond R (2012) Ciclosporin modulates the responses of canine progenitor epidermal keratinocytes (CPEK) to toll-like receptor agonists. Vet Immunol Immunopathol 147:91–96
Hightower K, Marsella R, Flynn-Lurie A (2010) Effects of age and allergen exposure on transepidermal water loss in a house dust mite-sensitized beagle model of atopic dermatitis. Vet Dermatol 21:88–95. doi:10.1111/j.1365-3164.2009.00839.x
Hill PB, Hillier A, Olivry T (2001) The ACVD task force on canine atopic dermatitis (VI): IgE-induced immediate and late-phase reactions, two inflammatory sequences at sites of intradermal allergen injections. Vet Immunol Immunopathol 81:199–204
Hill PB, Lo A, Eden CA, Huntley S, Morey V, Ramsey S, Richardson C, Smith DJ, Sutton C, Taylor MD, Thorpe E, Tidmarsh R, Williams V (2006) Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec 158:533–539
Hill P, Rybnicek J, Lau-Gillard P (2010) Correlation between pruritus score and grossly visible erythema in dogs. Vet Dermatol 21:450–455
Jackson HA, Hammerberg B (2002) Evaluation of a spontaneous canine model of immunoglobulin E-mediated food hypersensitivity: Dynamic changes in serum and fecal allergen-specific immunoglobulin E values relative to dietary change. Comp Med 52:316–321
Kimura T, Sekido M, Iio A, Chimura N, Shibata S, Kamishina H, Kamishina H, Maeda S (2013) Involvement of nuclear factor of activated T cells in granulocyte-macrophage colony-stimulating factor production in canine keratinocytes stimulated with a cysteine protease. Vet Dermatol 24(310–4):e69
Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314:1310–1321
Marsella R, Nicklin C, Lopez J (2006a) Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites. Vet Dermatol 17:306–312
Marsella R, Olivry T, Nicklin C, Lopez J (2006b) Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs. Vet Dermatol 17:24–35
Marsella R, Samuelson D, Doerr K (2010) Transmission electron microscopic studies in an experimental model of canine atopic dermatitis. Vet Dermatol 21:81–88
Marsella R, Olivry T, Carlotti DN, for the International Task Force on Canine Atopic Dermatitis (2011) Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet Dermatol 22:239–248
Nuttall TJ, McEwan NA, Bensignor E, Cornegliani L, Lowenstein C, Reme CA (2012) Comparable efficacy of a topical 0.0584 % hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Vet Dermatol 23(4–10):e1–2
Olivry T (2011) Is the skin barrier abnormal in dogs with atopic dermatitis? Vet Immunol Immunopathol 144:11–16
Olivry T, Bizikova P (2013) A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008–2011 update. Vet Dermatol 24:97–117.e25-6
Olivry T, Mueller RS (2003) Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet Dermatol 14:121–146
Olivry T, Foster AP, Mueller RS, McEwan NA, Chesney C, Williams HC (2010) Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Vet Dermatol 21:4–22
Olivry T, Wofford J, Paps JS, Dunston SM (2011) Stratum corneum removal facilitates experimental sensitization to allergens in atopic dogs. Vet Dermatol 22:188–196
Olivry T, Bizikova P, Paps JS, Dunston S, Lerner EA, Yosipovitch G (2013) Cowhage can induce itch in the atopic dog. Exp Dermatol 22:435–437
O'Shea JJ, Plenge R (2012) JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36:542–550
Otsuka A, Tanioka M, Nakagawa Y, Honda T, Ikoma A, Miyachi Y, Kabashima K (2011) Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis. Eur J Dermatol 21:816–817
Pucheu-Haston CM, Shuster D, Olivry T, Brianceau P, Lockwood P, McClanahan T, de Waal MR, Mattson JD, Hammerberg B (2006) A canine model of cutaneous late-phase reactions: prednisolone inhibition of cellular and cytokine responses. Immunology 117:177–187
Pucheu-Haston CM, Jackson HA, Olivry T, Dunston SM, Hammerberg B (2008) Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis. Clin Exp Allergy 38:667–679
Puigdemont A, Brazis P, Ordeix L, Dalmau A, Fuertes E, Olivar A, Perez C, Ravera I (2013) Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs. Vet J 197:280–285
Rossbach K, Stark H, Sander K, Leurs R, Kietzmann M, Baumer W (2009) The histamine H receptor as a new target for treatment of canine inflammatory skin diseases. Vet Dermatol 20:555–561
Rossbach K, Nassenstein C, Gschwandtner M, Schnell D, Sander K, Seifert R, Stark H, Kietzmann M, Baumer W (2011) Histamine H1, H3 and H4 receptors are involved in pruritus. Neuroscience 190:89–102
Rybnicek J, Lau-Gillard PJ, Harvey R, Hill PB (2009) Further validation of a pruritus severity scale for use in dogs. Vet Dermatol 20:115–122
Sekine R, Satoh T, Takaoka A, Saeki K, Yokozeki H (2012) Anti pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen-induced scratching behavior. Exp Dermatol 21:201–204
Simons FE, Simons KJ (2011) Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 128:1139–1150.e4
Stahl J, Paps J, Baumer W, Olivry T (2012) Dermatophagoides farinae house dust mite allergen challenges reduce stratum corneum ceramides in an experimental dog model of acute atopic dermatitis. Vet Dermatol 23:497–e97
Stander S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard JD (2007) Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 87:291–294
Steffan J, Favrot C, Mueller R (2006) A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet Dermatol 17:3–16
Wheeler DW, Civil J, Payne-Johnson M, Stegemann MR, Cosgrove SB (2012) Oclacitinib for the treatment of pruritus and lesions associated with canine flea allergy dermatitis. Vet Dermatol 23 (Suppl. 1):38 (abstract)
Wilson SR, The L, Batia LM, Beattie K, Katibah GE, McClain SP, Pellegrino M, Estandian DM, Bautista DM (2013) The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155:285–295
Wuersch K, Brachelente C, Doherr M, Reist M, Sattler U, Forster U, Bertoni G, Peel JE, Welle M (2006) Immune dysregulation in flea allergy dermatitis—a model for the immunopathogenesis of allergic dermatitis. Vet Immunol Immunopathol 110:311–323
Zampeli E, Tiligada E (2009) The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 157:24–33
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Olivry, T., Bäumer, W. (2015). Atopic Itch in Dogs: Pharmacology and Modeling. In: Cowan, A., Yosipovitch, G. (eds) Pharmacology of Itch. Handbook of Experimental Pharmacology, vol 226. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44605-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-662-44605-8_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44604-1
Online ISBN: 978-3-662-44605-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)